Bausch Health reports Q4 and FY2022 results; press release not provided in filing

Bausch Health Companies Inc.

2022-FY EPS reported -$0.62 revenue$8,124,000,000

Company issued press release on Feb 23, 2023 for Q4 and year ended Dec 31, 2022.
Exhibit 99.1 referenced but not included in the user message; specific financial data unavailable.
No revenue, EPS, or segment details can be extracted from the provided text.
Filing is under Item 2.02 (results) and Item 9.01 (exhibits).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

Bausch Health Companies Inc. reported financial results for the quarter and the year ended December 31, 2022.

Period: the quarter and the year ended December 31, 2022
Result: reported results

Exact text from the filing

On February 23, 2023, Bausch Health Companies Inc. (the “Company”) issued a press release announcing results of operations for the quarter and the year ended December 31, 2022

View on SEC.gov

Browse all earnings releases →

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR

accession 0000885590-23-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.